Marechale Capital Plc - Half-year Report
PR Newswire
LONDON, United Kingdom, January 19
19 January 2026
Marechale Capital plc
("Marechale Capital", "Marechale" or the "Company")
Half-yearly Results
Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2025 (the "Period").
Chairman's Statement
A difficult first half to the Company's year has been a feature of recent years, with 2025 being no exception, particularly with the SME market being challenging. However, the market started to pick up in November 2025, and there has been a healthy new business pipeline developing in recent months.
During the six months ended 31 October 2025, the Company generated a gross profit of £55,310 (2024: £103,468) and delivered an operating loss of £177,066 (2024: loss of £138,485 ), resulting in an overall loss before tax of £176,515 (2024: loss of £178,261).
The Company's balance sheet shows a net asset value of £3,063,198 (2024: £3,183,537), representing 2.56p (2024: 3.01p) of value per share in issue. The Board remains positive about the investments that it holds in its client companies, and in particular its core investment in Weardale Lithium.
Whilst there have been delays in completing some advisory projects during the Period, on a positive note, Marechale has in the last few months completed both debt and equity growth round transactions for Wright Brothers, the UK's leading premium fish wholesaler and restaurant operator, KBH, one of the UK's leading 'out of home' media companies on the UK's railways and cinemas, Weardale Lithium, which has received planning for the UK's first Direct Lithium Extraction plant and Chestnut Inns, one of the UK's leading premium inn operators.
Cash at bank as at 31 October 2025 was £228,593 (2024: £223,700). However, in the months since the end of the Period, and based on the recent transactions that Marechale has completed, the Company has grown its cash at bank to £312,000 as at 14 January 2026.
The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with various potential businesses and individuals.
This plan to continue to develop Marechale's strategic partnerships in order to enhance shareholder value, and develop new funding partners alongside its traditional investor relationships, has culminated in the successful completion of a placing in Marechale shares in October (as previously announced); this brought in two new strategic investors as well, in addition to all the Company's directors investing too.
Marechale Capital continues to see interesting corporate finance and advisory projects; the Board believes despite the challenges of the last few years, that the SME market is looking more positive, and that there is a recognition of value in UK growth companies, particularly with new initiatives for the AIM markets, the Enterprise Investment Scheme (EIS), and the move to encourage more private and institutional funding into smaller UK companies.
Whilst the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will continue to be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term, where the Company can generate more value enhancing warrant and founding equity holdings alongside advisory cash fees. The Board is also hoping to agree terms on further strategic partnerships, and is in a number of advanced conversations with different parties.
Mark Warde-Norbury
Chairman
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
For further information please contact:
Marechale Capital Mark Warde-Norbury / Patrick Booth-Clibborn | Tel: +44 (0)20 7628 5582 |
Cairn Financial Advisers LLP Jo Turner / Sandy Jamieson | Tel: +44 (0)20 7213 0880 |
| Income Statement (unaudited) | ||||||||
| 6 months ended 31 October | 2025 | 2024 | ||||||
| £ | £ | |||||||
| Revenue | 111,932 | 148,500 | ||||||
| Cost of sales | (56,622) | (45,032) | ||||||
| Gross profit | 55,310 | 103,468 | ||||||
| Administrative expenses | (232,376) | (241,953) | ||||||
| Operating loss | (177,066) | (138,485) | ||||||
| Exceptional credit | 600 | 10,316 | ||||||
| Loss on disposal of investments | - | (49,837) | ||||||
| Interest paid | (49) | (255) | ||||||
| (Loss) before tax | (176,515) | (178,261) | ||||||
| Taxation | - | - | ||||||
| (Loss) after tax | (176,515) | (178,261) | ||||||
| (Loss) per share | ||||||||
| (Pence) | (Pence) | |||||||
| - Basic | (0.17) | (0.17) | ||||||
| - Diluted | (0.17) | (0.17) | ||||||
| Balance Sheet (unaudited) | |||||||
| As at | 31 October | 31 October | |||||
| 2025 | 2024 | ||||||
| Current assets | |||||||
| Available for sale investments | 2,807,829 | 2,939,660 | |||||
| Trading investments | 58,800 | 49,953 | |||||
| Trade and other receivables | 91,172 | 52,856 | |||||
| Cash and cash equivalents | 228,593 | 223,712 | |||||
| 3,186,394 | 3,266,181 | ||||||
| Current liabilities | |||||||
Trade and other payables PAYE Bounce-back Loan | (110,811) (4,885) (7,500) | (54,338) (10,806) (10,000) | |||||
| Total current liabilities | (123,196) | (75,144) | |||||
| Net current assets | 3,063,198 | 3,191,037 | |||||
| Bounce-back Loan - long-term | - | (7,500) | |||||
| Net assets | 3,063,198 | 3,183,537 | |||||
| Equity | |||||||
| Capital and reserves attributable to equity shareholders | |||||||
Share capital Share premium | 955,530 575,790 | 847,530 481,290 | |||||
| Reserve for own shares | (50,254) | (50,254) | |||||
| Retained profits/ (losses) | 1,403,817 | 1,739,397 | |||||
| Reserve for share based payments | 178,315 | 165,574 | |||||
| 3,063,198 | 3,183,537 | ||||||
| Cash Flow Statement (unaudited) | ||||||
| 6 months ended | 31 October | 31 October | ||||
| 2024 | ||||||
| £ | ||||||
| Net cash from operating activities | ||||||
| Loss after tax | (176,515) | (178,261) | ||||
| Reverse exceptional credits | (600) | (10,316) | ||||
| Loss of disposal of investments | - | 49,837 | ||||
Provision for share based payments Reverse interest paid | - 49 | 15,406 255 | ||||
| Operating cash flows before movements in working capital | (177,066) | (123,079) | ||||
| Movement in working capital | ||||||
| Decrease/ (increase) in receivables | 13,852 | (7,950) | ||||
| (Decrease)/ Increase in payables | (17,795) | 3,108 | ||||
| Net movement in working capital | (3,942) | (4,842) | ||||
| Operating cash out-flow | (181,009) | (127,921) | ||||
| Investment activities | ||||||
| Expenditure on available for sale investments | - | - | ||||
| Proceeds from sale of investments and options | - | 108,692 | ||||
| Cash flow from investing activities | - | 108,692 | ||||
Financing Share Capital Bounce-back Loan repayments Interest paid Net financing | 202,500 (5,000) (48) 197,452 | - (5,000) (255) (5,255) | ||||
| Net Increase / (decrease) in cash and cash equivalents | 16,443 | (24,484) | ||||
| Cash and cash equivalents at start of the period | 212,150 | 248,196 | ||||
| Cash and cash equivalents at end of the period | 228,593 | 223,712 | ||||
| Increase / (decrease) in cash and cash equivalents | 16,443 | (24,484) | ||||
This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.
